The place of artificial oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation

Canadian Journal of Anesthesia

Volumn 50, Issue 6 SUPPL., 2003, Pages

  Spahn, Donat R ^a   Kocian, Roman ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; EFAPROXIRAL; FLUOROCARBON; HEMOGLOBIN; LIPOSOME; OXYGEN; PERFLUOROOCTYL BROMIDE; POLYMERIZED HEMOGLOBIN; RAFFINOSE;

ALLOGRAFT; BLOOD TRANSFUSION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG HALF LIFE; EMULSION; ERYTHROCYTE CONCENTRATE; FEVER; FLU LIKE SYNDROME; HEMODILUTION; HUMAN; METABOLISM; MYALGIA; ORTHOPEDIC SURGERY; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SURGICAL TECHNIQUE; TISSUE OXYGENATION; VASOCONSTRICTION;

BLOOD SUBSTITUTES; BLOOD TRANSFUSION; FLUOROCARBONS; HEMOGLOBINS; HUMANS; LIPOSOMES; OXYGEN CONSUMPTION;

EID: 0042035626     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Tremper KK. Perfluorochemical "blood substitutes" indications for an oxygen carrying colloid. Anesthesiology 1999; 91: 1185-7.
2. Levy JH. Hemoglobin-based oxygen-carrying solutions: close but still so far. Anesthesiology 2000; 92: 639-41.
3. Vlahakes GJ. Hemoglobin solutions come of age. Anesthesiology 2000; 92: 637-8.
4. Klein HG. The prospects for red-cell substitutes. N Engl J Med 2000; 342: 1666-8.
5. Stowell CP, Levin J, Spiess BD, Winslow RM. Progress in the development of RBC substitutes. Transfusion 2001; 41: 287-99.
6. Spahn DR, Pasch T. Physiological properties of blood substitutes. News Physiol Sci 2001; 16: 38-41.
7. Winslow RM. Blood substitutes. Adv Drug Deliv Rev 2000; 40: 131-42.
8. Phillips WT, Klipper RW, Awasthi VD, et al. Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. J Pharmacol Exp Ther 1999; 288: 665-70.
9. Rabinovici R, Rudolph AS, Vernick J, Feuerstein G. Lyophilized liposome encapsulated hemoglobin: evaluation of hemodynamic, biochemical, and hematologic responses. Crit Care Med 1994; 22: 480-5.
10. Rudolph AS, Sulpizio A, Hieble P, et al. Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments. J Appl Physiol 1997; 82: 1826-35.
11. Pagel PS, Hettrick DA, Montgomery MW, et al. RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs. J Pharmacol Exp Ther 1998; 285: 1-8.
12. Wahr JA, Gerber M, Venitz J, Baliga N. Allosteric modification of oxygen delivery by hemoglobin. Anesth Analg 2001; 92: 615-20.
13. Spahn DR, Willimann PF, Faithfull NS. [The effectiveness of augmented acute normovelemic hemodilution (A-ANH)]. Wirksamkeit der Augmentierten Akuten Normovolämen Hämodilution (A-ANH) (German . Anaesthesist 2001; 50(Suppl 1): S49-54.
14. Spahn DR, Leone BJ, Reves JG, Pasch T. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 1994; 78: 1000-21.
15. Xu L, Sun L, Rollwagen FM, et al. Cellular responses to surgical trauma, hemorrhage, and resuscitation with diaspirin cross-linked hemoglobin in rats. J Trauma 1997; 42: 32-41.
16. Sielenkämper AW, Chin Yee IH, Martin CM, Sibbald WJ. Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats. Am J Respir Crit Care Med 1997; 156: 1066-72.
17. Meisner FG, Kemming GI, Habler OP, et al. Diaspirin crosslinked hemoglobin enables extreme hemodilution beyond the critical hematocrit. Crit Care Med 2001; 29: 829-38.
18. Habler O, Kleen M, Pape A, et al. Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis. Crit Care Med 2000; 28: 1889-98.
19. Viele MK, Weiskopf RB, Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology 1997; 86: 848-58.
20. Kasper SM, Walter M, Grüne F, et al. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996; 83: 921-7.
21. Dietz NM, Martin CM, Beltrandelrio AG, Joyner MJ. The effects of cross linked hemoglobin on regional vascular conductance in dogs. Anesth Analg 1997; 85: 265-73.
22. Gulati A, Sharma AC, Singh G. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 1996; 24: 137-47.
23. Gulati A, Rebello S. Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 1994; 124: 125-33.
24. Gould SA, Moss GS. Clinical development of human polymerized hemoglobin as a blood substitute. World J Surg 1996; 20: 1200-7.
25. Keipert PE, Gomez CL, Gonzales A, et al. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med 1994; 123: 701-11.
26. Ning J, Wong LT, Christoff B, et al. Haemodynamic response following a 10% topload infusion of Hemolink™ in conscious, anaesthetized and treated spontaneously hypertensive rats. Transfus Med 2000; 10: 13-22.
27. Winslow RM. Alphaalpha-crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang 2000; 79: 1-20.
28. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994; 331: 1105-9.
29. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 1999; 282: 1857-64.
30. Lamy ML, Daily EK, Brichant JF, et al. Randomized trial of Diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. Anesthesiology 2000; 92: 646-56.
31. Levy JH, Goodnough LT, Greilich PE, et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized double-blind trial. J Thorac Cardiovasc Surg 2002; 124: 35-42.
32. Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998; 187: 113-20.
33. Cheng DC, Martineau R, MacAdams C, et al. Safety of Hemolink as an oxygen therapeutic in patients undergoing coronary artery bypass graft surgery. Anesth Analg 2001; 92(Suppl.): SCA3.
34. Jahr JS. A novel blood substitute: use of HBOC-201 (Hemopure) to decrease need for RBC: results of pivotal trial in orthopedic surgery patients. Crit Care Med 2001; 29(Suppl.): A168.
35. Sprung J, Kindscher JD, Wahr JA, et al. The use of bovine hemoglobin glutamer-250 (Hemopure) in suergical patients: results of a multicenter, randomized single-blind study. Anesth Analg 2002; 94: 799-808.
36. Ma Z, Monk TG, Goodnough LT, et al. Effect of hemoglobin- and perflubron-based oxygen carriers on common clinical laboratory tests. Clin Chem 1997; 43: 1732-7.
37. Ali AA, Ali GS, Steinke JM, Shepherd AP. Co-oximetry interference by hemoglobin-based blood substitutes. Anesth Analg 2001; 92: 863-9.
38. Reppucci AJ, Mattia Goldberg C, Przybelski RJ, et al. The effects of diaspirin-crosslinked hemoglobin on the assessment of immunohematology profiles. Transfusion 1997; 37: 1143-8.
39. Riess JG. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Biomater Artif Cells Immobil Biotechnol 1992; 20: 183-202.
40. Wahr JA, Trouwborst A, Spence RK, et al. A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth Analg 1996; 82: 103-7.
41. Keipert PE. Perfluorochemical emulsions: future alternatives to transfusion. Blood Substitutes Principles Methods Products And Clinical Trials 1998; 2: 127-56.
42. Riess JG, Keipert PE. Update on perfluorocarbon-based oxygen delivery systems. In: Tsuchida E (Ed.). Blood Substitutes - Present and Future Perspectives. Lausanne: Elsevier Science S. A.; 1998: 91-102.
43. Leese PT, Noveck RJ, Shorr JS, et al. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth Analg 2000; 91: 804-11.
44. Keipert PE, Faithfull NS, Bradley JD, et al. Oxygen delivery augmentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution. Adv Exp Med Biol 1994; i45: 197-204.
45. Holman WL, Spruell RD, Ferguson ER, et al. Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995; 110: 774-85.
46. Habler OP, Kleen MS, Hutter JW, et al. Effects of hyperoxic ventilation on hemodilution-induced changes in anesthetized dogs. Transfusion 1998; 38: 135-44.
47. Habler OP, Kleen MS, Hutter JW, et al. Iv perflubron emulsion versus autologous transfusion in severe normovolemic anemia: effects on left ventricular perfusion and function. Res Exp Med 1998; 197: 301-18.
48. Spahn DR, van Bremt R, Theilmeier G, et al. Perflubron emulsion delays blood transfusion in orthopedic surgery. Anesthesiology 1999; 91: 1195-208.
49. Noveck RJ, Shannon EJ, Leese PT, et al. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. Anesth Analg 2000; 91: 812-22.
50. Spahn DR, Waschke K, Standl T, et al. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study. Anesthesiology 2002; 97: 1338-49.
51. Keipert PE, Faithfull NS, Roth DJ, et al. Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier. Adv Exp Med Biol 1996; 388: 603-9.
52. Frumento RJ, Mongero LM, Naka Y, Bennett Guerrero E. Preserved gastric tonometric variables in cardiac surgical patients administered intravenous perflubron emulsion. Anesth Analg 2002; 94: 809-14.
53. Cheng DC. Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery. Can J Anesth 2001; 48: S41-8.
54. Spahn DR. Blood substitutes: artificial oxygen carriers: perfluorocarbon emulsions. Crit Care 1999; 3: R93-7.
55. Looker D, Abbott-Brown D, Cozart P, et al. A human recombinant haemoglobin designed for use as a blood substitute. Nature 1992; 356: 258-60.